Skip to main content
. 2022 Mar 4;44(3):275–278. doi: 10.1016/j.ejr.2022.03.001

Table 1.

Cases of acute arthritis following corona virus disease 2019 (COVID-19) infection.

Reference Age (y)/sex COVID-19 infection severity* Duration till arthritis (days) Involved joints Inflammatory Biomarkers Immune profile (RF, ACPA, ANA) HLA genotyping Arthritis management
Derksen et al. [13] 67/male Moderate to severe Already present small/large ESR: 36 mm/1st hr
CRP: 6 mg/L
N.S N.S N.S
49/male 42 small/large ESR: 79 mm/1st hr
CRP: 449 mg/L
N.S N.S N.S
67/female 98 small ESR: 49 mm/1st hr CRP: 168 mg/L N.S N.S N.S
65/male 3 small/large ESR: 26 mm/1st hr
CRP: 6 mg/L
N.S N.S N.S
Perrot et al. [14] 60/female Mild 25 MCP/IP CRP: 18.5 mg/L
IL-6: 31 pg/mL
Positive ACPA,
ANA, anti-SSA/SSB, anti-DNA.
Negative RF
No classic
HLA genotype†
Methotrexate (10 mg/w)
Baimukhamedov et al. [15] 67/male Severe 37 Knees/hands ESR: 59 mm/1st hr
CRP: 55 mg/L
RF: 411 IU/ml
ACPA§: 104 IU/ml
N.S Methotrexate (15 mg/w)
Methylprednisolone (8 mg/d)
Roongta et al. [16] 56/female Severe 14 Knees/wrists Elevated CRP and ESR RF§: 131 IU/mL
ACPA§: 35 IU/ml
N.S Methotrexate (15 mg/w)
This case 72/female Asympt-omatic 15 MCP/PIP/wrists/knees ESR: 95 mm/1st hr
CRP: 108 mg/L
Increased α-2 and γ-globulins
IL-6: 16.5 pg/mL
RF: 128
ACPA:200
ANA: 1:320
DRB1*04:11, DQB1*03:01, DQB1* 03:02. Methotrexate (10 mg/w)
Steroids

RF: rheumatoid factor, ACPA: anti-cyclic citrullinated peptide antibodies, ANA: antinuclear antibodies, NS: not specified, MCP: metacarpophalangeal, IP: interphalangeal, PIP: proximal IP, HLA: Human Leukocyte Antigen, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate. * Symptoms of COVID-19 infection were collected and severity was classified as 4 levels: mild, moderate, severe, and critical.

†:HLA-A*01:01, HLA-A*02:01; HLA-B*08:01, HLA-B*1402; HLA-C*07:01, HLA-C*08:02; HLA-DRB1*15:01, HLA-DRB1*--; HLA-DQB1*06:02, HLA-DQB1*--. §: initially negative. ¶: From the five cases of rheumatoid arthritis (RA) reported by Derksen et al, we included the four cases of new-onset RA. One patient was excluded because he had a history of RA prior to COVID-19 infection.